ContextVision Announces New Leadership Team, Appoints Ola Lindblad as CEO

Report this content

STOCKHOLM – February 14, 2022ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business.

Previous leaders at ContextVision will assume new roles, including the appointment of Ola Lindblad as interim CEO; Lindblad formerly served as VP, Medical Imaging. Lindblad will now lead the new organization to directly focus on image quality for medical imaging, the long-time roots of the company. Additional appointments include Katarina Flood, chief services officer (CSO), Ann-Sofi Hoff, chief product officer (CPO), and Gunnar Läthén, CTO. Markus Hökerberg joins ContextVision as the new CFO.

Former ContextVision CEO Fredrik Palm will lead the digital pathology spin-off, Inify Laboratories, as previously announced.

New Leadership Team

  • Ola Lindblad, CEO
  • Markus Hökerberg, CFO
  • Gunnar Läthén, CTO
  • Ann-Sofi Hoff, CPO
  • Katarina Flood, CSO

“ContextVision is a unique brand in the medical imaging market with exceptionally talented people. I’m honored and humbled to take on this leadership role. The new management team is already in place, active and committed to leading the business forward. With a laser-focus on image quality, we will continue our growth trajectory for the coming years,” CEO Ola Lindblad commented.

For more information, please visit


About ContextVision

ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world.

Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.

The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.

Media contact:

Mark O’Toole

+1 (781) 353.7007